Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction?

Journal of Family Practice

Volumn 54, Issue 4, 2005, Pages 370-372

  Singh, Amrit ^a   Blackwell, Jean ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IBOPAMINE; LOOP DIURETIC AGENT; PERTANIDE; PLACEBO; POTASSIUM SPARING DIURETIC AGENT; UNCLASSIFIED DRUG; DIURETIC AGENT;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; ELECTROLYTE DISTURBANCE; EXERCISE; HEART LEFT VENTRICLE OVERLOAD; HUMAN; LUNG EDEMA; META ANALYSIS; MORBIDITY; MORTALITY; NEUROENDOCRINE DISEASE; PERIPHERAL EDEMA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; REVIEW; SUDDEN DEATH; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; DRUG EFFECT; EXERCISE TOLERANCE; HOSPITAL READMISSION;

DIURETICS; EXERCISE TOLERANCE; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HUMANS; PATIENT READMISSION; TREATMENT OUTCOME;

EID: 16844371770     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Reyes AJ. Diuretics in the treatment of patients who present congestive heart failure and hypertension. J Hum Hypertens 2002; 16 Suppl 1:S104-S113.
2. van Kraaij DJ, Jansen RW, Gribnau FW, Hoefnagels WH. Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction. Drugs Aging 2000; 16:289-300.
3. Kramer BK, Schweda F, Riegger GAJ. Diuretic treatment and diuretic resistance in heart failure. Am J Med 1999; 106:90-96.
4. Faris R, Flather M, Purcell H, Henein M, Poole-Wilson P, Coats A. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 2002; 82:149-158.
5. Parker JO. The effects of oral ibopamine in patients with mild heart failure - a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group. Int J Cardiol 1993; 40: 221-227.
6. Domanski M, Norman J, Pitt B, et al. Diuretic use, progressive heart failure, and death in patients in the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003; 42:705-708.
7. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999; 100:1311-1315.
8. Neuberg GW, Miller AB, O'Connor CM, et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 2002; 144:31-38.
9. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). 2001. American College of Cardiology. Last updated March 12, 2002. Available at: www.acc.org/clinical/guidelines/failure/hf_index. htm. Accessed on March 4, 2005.
10. Remme WJ, Swedberg K; Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22:1527-1560.